Detection of p53 Mutation in Colorectal Cancer Using PCR-SSCP and DHPLC

대장암에서 PCR-SSCP와 DHPLC를 이용한 p53 돌연변이의 검출

  • Sang-Bum Park (Department of Chemistry, College of Natrural Science, Dankook University) ;
  • Sang-Man Han (Department of Chemistry, College of Natrural Science, Dankook University) ;
  • Youn-Hyoung Nam (Department of Chemistry, College of Natrural Science, Dankook University) ;
  • Won-Cheoul Jang (Department of Chemistry, College of Natrural Science, Dankook University)
  • 박상범 (단국대학교 자연과학대학 화학과) ;
  • 한상만 (단국대학교 자연과학대학 화학과) ;
  • 남윤형 (단국대학교 자연과학대학 화학과) ;
  • 장원철 (단국대학교 자연과학대학 화학과)
  • Published : 2003.10.20


Structural alteration of p53 and overexpression of p53 protein are the most common genetic abnormalities in various kinds of human cancer. Mutations in the p53 tumor-suppressor gene are usually associated with an advanced development of colorectal cancer characterized by the transition from the adenoma to carcinoma stage. Mutations in exons 5-8 of the p53 gene were analyzed by the polymerase chain reaction-single strand conformation polymorphism(PCR-SSCP) and denaturing high performance liquid chromatography(DHPLC). SSCP analysis detected 7 mutations(C13109>T) in 50 colorectal cancer samples(14%) at exon 5, and DHPLC analysis detected 7 mutations (C13109>T) and 2 mutation(C13202>A, C13204>G) in 50 colorectal cancer samples(18%) at exon 5. All of 9 mutations were proved by sequencing analysis. We conclude that DHPLC is a highly sensitive and specific method for p53 gene mutations.


p53; Colorectal Cancer; PCR-SSCP; DHPLC,;Mutation


  1. Hollstein, M.; Shomer, B.; Greenblatt, M.; Soussi, T.; Hovig, E.; Montesano, R.; Haarris, C. C. Nucleic Acid Res. 1996, 24, 141-146.
  2. Xiao, W. and Oefner P. J. Hum. Mutat. 2001, 17, 439-474.
  3. Gross, E.; Arnold, N.; Pfeifer, K.; Bandick, K.; Kiechle, M. Hum. Mutat. 2000, 16, 345-353.<345::AID-HUMU7>3.0.CO;2-#
  4. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S. Hum. Mutat. 2000, 16, 68-76.<68::AID-HUMU12>3.0.CO;2-U
  5. Kim, J.; Takahashi, T., Chiba, I.; Park, J. G.; Birrer, M. J.; Roh, J. K.; Lee, H.; Kim, J. P.; Minna, J. D.; Gazda, A. F. J Natl Cancer Inst. 1999, 83, 938-943.
  6. Greenblatt, M. S.; Bennett, W. P.; Hollstein, M.; Harris, C. C. Cancer Res. 1994, 53, 4855-4878.
  7. Hansen, N. F.; Oefner, P. J. 1997, U.S. Patent 5795976.
  8. Gannon, J. V.; Greave, R.; Iggo, R.; Lane, D. P. EMBO J. 1990, 9, 1595-1602.
  9. Jones, A. C.; Austin, J.; Hansen, N.; Hoogendoorn, B.; Oefner, P. J. Cheadle, J. P.; O'Donovan, M. C. Clin. Chem. 1999, 45, 1133-1140.
  10. T. Wagner, D. Stoppa-Lyonnet, E. Fleischmann, D. Muhr, S. Pages, T. Sandberg, V. Caux, R. Moslinger, G. Langbauer, A. Borg and P. J. Oefner, Genomics 1999, 62, 369-376.
  11. Ellis, L. A.; Taylor, C. F.; Taylor, G. R. Hum. Mutat. 2000, 15, 556-64.<556::AID-HUMU7>3.0.CO;2-C
  12. Huber, C. G.; Berti, N. Anal. Chem. 1996, 68, 2959-2965.
  13. Takahashi, T.; Nau, M.; Chiba, M.; Birrer, M.J.; Rosenberg, R. K.; Vinocour, M.; Levitt, M.; Pass, H.; Gazdar, A. F.; Minna, J. D. Science 1989, 246, 491-494.
  14. Skopek, T. R.; Glaab, W. E.; Monroe, J. J.; Kort K. L.; Schaefer, W. Mutat. Res. 1999, 430, 13-21.
  15. Benit, P.; Kara-Mosterfa, A.; Berthelon, M.; Sengmany, K.; Bonnefont, J. P. Hum. Mutat. 2000, 16, 417-421.<417::AID-HUMU6>3.0.CO;2-4
  16. Murphree, A. L.; Benedict, W. F.; Retinoblastoma. Science 1984, 223, 1028-1033.
  17. Hollstein, M.; Sidrowsky, D.; Vogelstein, B.; Harris, C.C. Science 1991, 253, 49-53.
  18. Oefner, P. J.; Bonn, G. K. Amer. Lab. 1994, 26, 28C-28J.
  19. Soussi, T.; Fromental, C.C.; May, P. Oncogene 1990, 5, 945- 952.
  20. Oefner, P. J.; Underhill, P. A. 1998, U.S. Patent 5795976.